Assuntos
Imunossupressores/farmacologia , Transplante de Rim , Maconha Medicinal/efeitos adversos , Dor Pós-Operatória/tratamento farmacológico , Tacrolimo/farmacologia , Acatisia Induzida por Medicamentos/etiologia , Interações Medicamentosas , Feminino , Humanos , Pessoa de Meia-Idade , Taquicardia/induzido quimicamenteRESUMO
Prostate cancer is now a chronic condition. Screening, diagnosis, and treatment pose specific psychosocial challenges for men diagnosed and surviving with prostate cancer. Depression, anxiety, and cognitive impairment lead to emotional distress and difficulty coping. Treatments for psychosocial distress are targeted at couples and individuals. Lifestyle modification may improve coping and quality-of-life indicators.
Assuntos
Neoplasias da Próstata/diagnóstico , Medicina Psicossomática , Adaptação Psicológica , Idoso , Idoso de 80 Anos ou mais , Antagonistas de Androgênios/efeitos adversos , Antagonistas de Androgênios/uso terapêutico , Comorbidade , Transtorno Depressivo/epidemiologia , Transtorno Depressivo/psicologia , Disfunção Erétil/epidemiologia , Disfunção Erétil/psicologia , Humanos , Acontecimentos que Mudam a Vida , Masculino , Neoplasias da Próstata/epidemiologia , Neoplasias da Próstata/terapia , Qualidade de Vida , Estresse Psicológico/etiologia , Estresse Psicológico/psicologiaRESUMO
Serotonin syndrome is a potentially lethal complication of antidepressant therapy. Cardiac surgical patients are at particularly high risk of serotonin syndrome due to the prevalence of depression in patients with advanced cardiac disease, many of whom receive multiple serotonergic agents in the perioperative period. Here, we describe a case of postoperative serotonin syndrome following methylene blue administration for perioperative vasoplegia during left ventricular assist device implantation. We additionally describe an institution-specific strategy to minimize future occurrences of serotonin syndrome in this high-risk population.
RESUMO
Breast cancer is a relatively common diagnosis for American women and depressive symptoms occur in many women with breast cancer. Identification of women with breast cancer and concomitant depressive symptoms and mood disorders requires particular attention by heath care providers, and may be aided by the administration of a variety of diagnostic and/or screening tools. Insomnia is also a significant problem for women with breast cancer at various stages of diagnosis and treatment, including after remission. Although many studies on the treatment of depression in women with breast cancer have been done, and the data do point to the efficacy of several antidepressants in this population, there are no data to support the widely held hypothesis that treatment of depression in patients with breast cancer may positively affect morbidity and mortality. Breast cancer treatments may give rise to depressive symptoms and this should be considered in the approach to pharmacotherapy. Several psychotherapeutic modalities offer relief of the symptoms and syndromes of depression in breast cancer. Future research can answer the question of which approach is most appropriate for which patients, and whether therapy can improve a variety of health outcomes and survival for women with breast cancer.